#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Breast cancer Rosai-Dorfman syndrome Pleomorphic leiomyosarcoma Subdural haematoma Behcet's syndrome Basal cell naevus syndrome Oesophageal squamous cell carcinoma stage II Immunodeficiency congenital Medulloblastoma Metastases to peritoneum Nasopharyngeal cancer Fibrodysplasia ossificans progressiva Pyruvate kinase deficiency anaemia Fms-like tyrosine kinase 3 positive More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Basic Information Cholangitis sclerosing – Life with Disease Metachromatic leukodystrophy – Diagnostics Immunodeficiency congenital – Trials in Disease Osteosarcoma recurrent – Life with Disease Optic glioma Hereditary motor and sensory neuropathy – Trials in Disease Idiopathic pulmonary fibrosis Nephrotic syndrome – Basic Information Toxic epidermal necrolysis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludeoxyglucose (18F) PALAZESTRANT Afamelanotide Tecaginlimab Human Mesenchymal Stem Cells Blu-222 Siplizumab Ioflupane (123I) Zofenopril Calcium Macrogol 4000 ZINC GLUCONATE Epinephrine Bitartrate Psilocybine Evolocumab Tazobactam Olodaterol Riboflavin Sodium Phosphate Elacestrant Emtricitabine Iomeprol More therapies…

    Learn about Your Condition

    Epidermolysis bullosa Dyspepsia Propionic acidaemia Non-Hodgkin's lymphoma Spinal muscular atrophy Catatonia Encephalopathy neonatal Hidradenitis Anxiety disorder Pharyngeal cancer stage I Urethral valves Androgenetic alopecia Rectal cancer stage II Myocarditis post infection Lennox-Gastaut syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Malignant melanoma stage II

  • Study of Pembrolizumab for Patients with Stage IIb/c Melanoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma stage II
    Investigated Drugs:
    • Pembrolizumab
    • Sodium Chloride
    Sweden

  • Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage II
    • Malignant melanoma stage III
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pemetrexed Disodium Hemipentahydrate
    • Pembrolizumab
    Lithuania Romania Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!